AR065079A1 - Procesos para la preparacion de n-(1-acilpiperidin-4-il)-n'-(adamant-1-il)urea e intermdediarios de dichos procesos. - Google Patents
Procesos para la preparacion de n-(1-acilpiperidin-4-il)-n'-(adamant-1-il)urea e intermdediarios de dichos procesos.Info
- Publication number
- AR065079A1 AR065079A1 ARP080100360A ARP080100360A AR065079A1 AR 065079 A1 AR065079 A1 AR 065079A1 AR P080100360 A ARP080100360 A AR P080100360A AR P080100360 A ARP080100360 A AR P080100360A AR 065079 A1 AR065079 A1 AR 065079A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- formula
- compound
- alkyl
- heterocyclic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 239000004202 carbamide Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 9
- 125000001072 heteroaryl group Chemical group 0.000 abstract 6
- 125000000623 heterocyclic group Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 3
- 125000003107 substituted aryl group Chemical group 0.000 abstract 3
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 239000012442 inert solvent Substances 0.000 abstract 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 150000003672 ureas Chemical class 0.000 abstract 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 abstract 1
- 229960003805 amantadine Drugs 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Se describen procesos para la síntesis de compuestos de urea sustituidos con piperidinilo. Se proveen también intermediarios preparados durante esta síntesis. Reivindicacion 1: Un proceso para la preparacion de compuestos de urea de la formula (1), en donde R1 se selecciona del grupo que consiste en alquilo, alquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, cicloalquilo, cicloalquilo sustituido, heterocíclico y heterocíclico sustituido, y m es cero, 1 o 2; caracterizado porque comprende: a) poner en contacto al menos una cantidad equimolar de un compuesto de la formula (2) R1C(O)X en donde X es -OH, halo u -OC(O)R, en donde R es alquilo, alquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, cicloalquilo, cicloalquilo sustituido, heterocíclico, o heterocíclico sustituido, con un compuesto de la formula (3), en un solvente inerte en condiciones que proveen un compuesto de la formula (4), b) poner en contacto el compuesto de la formula (4) producido en a) anterior con adamantilamina en presencia de un solvente inerte y un reactivo que convierte el grupo H2NC(O)- amido del compuesto de la formula (4) en un grupo isocianato en condiciones en las cuales el grupo isocianato reacciona con la amina de dicho grupo adamantilamina para formar el compuesto de la formula (1). Reivindicacion 14: Un compuesto de la formula (8a) o (8b) caracterizado porque es -CO-W, -SO2-W, o W, en donde W es alquilo, alquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, cicloalquilo, cicloalquilo sustituido, heterocíclico, o heterocíclico sustituido, con la condicion de que en la formula (8a) R7 no es -COCF3, -CH2-C6H5, o formula (11). Reivindicacion 15: Un compuesto de la formula (9) en donde R8 es alquilo C1-6. Reivindicacion 16: Un compuesto de la formula (10), caracterizado porque R9 es alquilo C1-6.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88711407P | 2007-01-29 | 2007-01-29 | |
| US97217707P | 2007-09-13 | 2007-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR065079A1 true AR065079A1 (es) | 2009-05-13 |
Family
ID=39493517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080100360A AR065079A1 (es) | 2007-01-29 | 2008-01-29 | Procesos para la preparacion de n-(1-acilpiperidin-4-il)-n'-(adamant-1-il)urea e intermdediarios de dichos procesos. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080207908A1 (es) |
| EP (1) | EP2125729A1 (es) |
| JP (1) | JP2010516785A (es) |
| KR (1) | KR20090107045A (es) |
| CN (1) | CN101663273A (es) |
| AR (1) | AR065079A1 (es) |
| AU (1) | AU2008210723A1 (es) |
| BR (1) | BRPI0807125A2 (es) |
| CA (1) | CA2675448A1 (es) |
| EA (1) | EA200901063A1 (es) |
| EC (1) | ECSP099599A (es) |
| IL (1) | IL199654A0 (es) |
| MX (1) | MX2009008093A (es) |
| TW (1) | TW200838851A (es) |
| WO (1) | WO2008094862A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090197916A1 (en) * | 2007-01-29 | 2009-08-06 | Arete Therapeutics, Inc | Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9216298D0 (en) * | 1991-08-15 | 1992-09-16 | Ici Plc | Piperidine derivatives |
| US7081454B2 (en) * | 2001-03-28 | 2006-07-25 | Bristol-Myers Squibb Co. | Tyrosine kinase inhibitors |
| JP4648317B2 (ja) * | 2003-08-01 | 2011-03-09 | 中外製薬株式会社 | マロニル−ＣｏＡデカルボキシラーゼ阻害剤として有用なピペリジン化合物 |
| TW200808723A (en) * | 2006-03-13 | 2008-02-16 | Univ California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
-
2008
- 2008-01-28 BR BRPI0807125-0A2A patent/BRPI0807125A2/pt not_active IP Right Cessation
- 2008-01-28 JP JP2009547453A patent/JP2010516785A/ja not_active Withdrawn
- 2008-01-28 CA CA002675448A patent/CA2675448A1/en not_active Abandoned
- 2008-01-28 EP EP08728391A patent/EP2125729A1/en not_active Withdrawn
- 2008-01-28 CN CN200880003369A patent/CN101663273A/zh active Pending
- 2008-01-28 EA EA200901063A patent/EA200901063A1/ru unknown
- 2008-01-28 MX MX2009008093A patent/MX2009008093A/es not_active Application Discontinuation
- 2008-01-28 TW TW097103103A patent/TW200838851A/zh unknown
- 2008-01-28 WO PCT/US2008/052196 patent/WO2008094862A1/en active Application Filing
- 2008-01-28 KR KR1020097015884A patent/KR20090107045A/ko not_active Application Discontinuation
- 2008-01-28 US US12/021,090 patent/US20080207908A1/en not_active Abandoned
- 2008-01-28 AU AU2008210723A patent/AU2008210723A1/en not_active Abandoned
- 2008-01-29 AR ARP080100360A patent/AR065079A1/es unknown
-
2009
- 2009-07-02 IL IL199654A patent/IL199654A0/en unknown
- 2009-08-27 EC EC2009009599A patent/ECSP099599A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090107045A (ko) | 2009-10-12 |
| EA200901063A1 (ru) | 2009-12-30 |
| CA2675448A1 (en) | 2008-08-07 |
| EP2125729A1 (en) | 2009-12-02 |
| US20080207908A1 (en) | 2008-08-28 |
| ECSP099599A (es) | 2009-09-29 |
| WO2008094862A1 (en) | 2008-08-07 |
| BRPI0807125A2 (pt) | 2014-04-08 |
| MX2009008093A (es) | 2009-08-12 |
| IL199654A0 (en) | 2010-04-15 |
| JP2010516785A (ja) | 2010-05-20 |
| TW200838851A (en) | 2008-10-01 |
| CN101663273A (zh) | 2010-03-03 |
| AU2008210723A1 (en) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1781683T3 (da) | Fremgangsmåde til fremstilling af 17-vinyl-triflater som halvfabrikata | |
| BRPI0516911A (pt) | método para a preparação de um composto e composto de anilina | |
| AR039150A1 (es) | Piridinoilpiperidinas como agonistas de 5-ht1f | |
| NO20091242L (no) | Fremgangsmate for fremstilling av biarylsubstituerte 4-aminosmorsyre eller derivater derav og deres anvendelse ved fremstilling av NEP-inhibitorer | |
| ATE472541T1 (de) | N-(1-alkyl-2-phenylethyl)carbonsäureamidderivat und deren verwendung als fungizide | |
| ATE373643T1 (de) | Als fungizide geeignete 2- pyridinylcycloalkylcarbonsäureamidderivate | |
| AR059201A1 (es) | Compuestos citotoxicos derivados de tomaimicina | |
| SG164384A1 (en) | Novel heterocyclic compound or salt thereof and intermediate thereof | |
| DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
| EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
| WO2008146871A1 (ja) | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規１，２，３，４－テトラヒドロキノキサリン誘導体 | |
| ATE477234T1 (de) | Synthese von phenolischen estern von hydroxymethylphenolen | |
| MX2010003148A (es) | Procedimiento para la preparacion de diamidas de acido sulfonico. | |
| EA200870038A1 (ru) | Способ получения аминов | |
| ATE521587T1 (de) | Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid | |
| AR047810A1 (es) | Proceso quimico | |
| NO20076000L (no) | Aminosyrederivater | |
| TNSN07395A1 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
| AR057451A1 (es) | Metodos para preparar derivados de acido glutamico | |
| AR051936A1 (es) | Proceso para la preparacion de pirazoles | |
| DK1948590T3 (da) | Fremgangsmåde til frembringelse af kontrastmidler | |
| BR0315112A (pt) | Sal de adição ácido, e, processo para a preparação de um composto | |
| NO20065789L (no) | Cinnamidforbindelse | |
| AR065079A1 (es) | Procesos para la preparacion de n-(1-acilpiperidin-4-il)-n'-(adamant-1-il)urea e intermdediarios de dichos procesos. | |
| ATE532516T1 (de) | Verfahren zur synthese von glyt-1-hemmern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |